Add to my calendar2019-06-13 18:30:002019-06-13 20:30:00Clinical Conundrums IV: 2019 Update
Overview: Please join us for a contemporary and clinically relevant educational activity which has been specifically designed to address the most frequently encountered clinical challenges in the management of patients with Atrial Fibrillation and the related co-morbidities in the primary care setting. This activity was developed by leading Canadian Experts to provide clinicians with answers to frequently asked questions and key take-away messages that can be applied to real-world practice.
Agenda:
Upon completion of this activity, participants should be able to:
Select personalized treatment options for stroke prevention in atrial fibrillation using current Canadian Practice Guidelines supplemented with reassuring “Real World” experience.
Assess and optimize bleeding risk of atrial fibrillation patients requiring long-term DOAC stroke prevention treatment.
Recognize the current treatment gap in Canada and take steps at ensuring appropriate dosage selection and long-term compliance with oral anticoagulation among AF patients.
Case 9: Optimizing the Use and Dosing of DOACs in Patients with AF: Upon completion of this activity, participants should be able to:
Apply the rationale for the appropriate use and non-use of community-based observational data (real-world data) in clinical practice.
Discuss real-world treatment patterns with OAC therapy.
Effectively manage the use and dosing of OAC therapy in patients with AF
Date: Thursday, June 13, 2019
Location: North 54, 1493 3rd Avenue, Prince George, BC
Speaker: Dr. Philip Teal
Moderator: Dr. Haidar Hadi
Registration: 6:30 pm (dinner to follow)
RSVP: Val Bernales, Phone: 604-679-3066 Email: val.bernales@pfizer.com
Accreditation: This one-credit-per-hour Group Learning program has been certified by the College of Family Physicians of Canada and the British Columbia Chapter for up to 1.50 Mainpro+ credits. This program has received an educational grant and in-kind support from BMS/Pfizer Alliance Canada
Disclaimer: The CME Event Calendar contains information originating from other sources. While every attempt is made to ensure that all information is accurately referenced, we do not guarantee the accuracy, quality or CME accreditation of posted events. Before registering for this event, please refer to the provincially harmonized CME Policy regarding reimbursement requirements for courses and conferences.
North 54
1493 3rd Avenue
Prince George V2L 3G1
Canada
Physician Educationphysician.education@northernhealth.caAmerica/Vancouverpublic
Add to Calendar: Start date2019-06-13 18:30:002024-04-24 09:06:36TitleDescriptionLocationPhysiciansrajbir.singh@opin.caAmerica/Vancouverpublic
Add to Calendar: End Date2024-04-24 09:06:362019-06-13 20:30:00Clinical Conundrums IV: 2019 Update
Clinical Conundrums IV: 2019 Update
North 54
1493 3rd Avenue
Prince George V2L 3G1
Canada
Physiciansrajbir.singh@opin.caAmerica/Vancouverpublic
Overview: Please join us for a contemporary and clinically relevant educational activity which has been specifically designed to address the most frequently encountered clinical challenges in the management of patients with Atrial Fibrillation and the related co-morbidities in the primary care setting. This activity was developed by leading Canadian Experts to provide clinicians with answers to frequently asked questions and key take-away messages that can be applied to real-world practice.
Agenda:
Upon completion of this activity, participants should be able to:
Select personalized treatment options for stroke prevention in atrial fibrillation using current Canadian Practice Guidelines supplemented with reassuring “Real World” experience.
Assess and optimize bleeding risk of atrial fibrillation patients requiring long-term DOAC stroke prevention treatment.
Recognize the current treatment gap in Canada and take steps at ensuring appropriate dosage selection and long-term compliance with oral anticoagulation among AF patients.
Case 9: Optimizing the Use and Dosing of DOACs in Patients with AF: Upon completion of this activity, participants should be able to:
Apply the rationale for the appropriate use and non-use of community-based observational data (real-world data) in clinical practice.
Discuss real-world treatment patterns with OAC therapy.
Effectively manage the use and dosing of OAC therapy in patients with AF
Date: Thursday, June 13, 2019
Location: North 54, 1493 3rd Avenue, Prince George, BC
Accreditation: This one-credit-per-hour Group Learning program has been certified by the College of Family Physicians of Canada and the British Columbia Chapter for up to 1.50 Mainpro+ credits. This program has received an educational grant and in-kind support from BMS/Pfizer Alliance Canada
Disclaimer: The CME Event Calendar contains information originating from other sources. While every attempt is made to ensure that all information is accurately referenced, we do not guarantee the accuracy, quality or CME accreditation of posted events. Before registering for this event, please refer to the provincially harmonized CME Policy regarding reimbursement requirements for courses and conferences.
Address:
North 54 1493 3rd Avenue Prince GeorgeV2L 3G1 Canada